Financial Comparison: EUDA Health (NASDAQ:EUDA) & Phreesia (NYSE:PHR)

Phreesia (NYSE:PHR) and EUDA Health (NASDAQ:EUDA) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, valuation, analyst recommendations and institutional ownership.

Earnings and Valuation

This table compares Phreesia and EUDA Health”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phreesia	$480.59 million	1.31	$2.31 million	$0.15	68.11
EUDA Health	$6.82 million	6.57	-$2.77 million	N/A	N/A

Phreesia has higher revenue and earnings than EUDA Health.

Institutional & Insider Ownership

92.1% of Phreesia shares are held by institutional investors. Comparatively, 4.3% of EUDA Health shares are held by institutional investors. 5.2% of Phreesia shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Phreesia and EUDA Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Phreesia	1.85%	5.13%	3.12%
EUDA Health	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Phreesia and EUDA Health, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phreesia	1	9	9	0	2.42
EUDA Health	1	1	1	0	2.00

Phreesia presently has a consensus target price of $16.65, indicating a potential upside of 62.93%. EUDA Health has a consensus target price of $55.00, indicating a potential upside of 266.91%. Given EUDA Health’s higher probable upside, analysts clearly believe EUDA Health is more favorable than Phreesia.

Risk & Volatility

Phreesia has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500. Comparatively, EUDA Health has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500.

Summary

Phreesia beats EUDA Health on 10 of the 12 factors compared between the two stocks.

About Phreesia

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.

About EUDA Health

EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, or residential apartments. EUDA Health Holdings Limited is headquartered in Singapore.